This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Dow-DuPont merger exemplifies difficulty in getting multi-jurisdictional antitrust approvals

By Curtis Eichelberger ( October 14, 2016, 21:10 GMT | Comment) -- The Dow-DuPont merger is one example of a growing concern for US companies. Receiving approval from multiple jurisdictions can delay deals, cost millions in regulatory and legal fees, lessen efficiencies created by the deal and introduce uncertainty that leads customers and employees to jump ship.When the proposed merger of agriculture giants Dow Chemical and DuPont was announced 10 months ago, the companies said they hoped to complete the deal by the second half of this year. But the need for approvals of multiple antitrust regimes, including the European Commission, will make that almost impossible now....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login